Drugs / Lipofundin MCT/LCT
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00497289 Comparator | Jan 2006 → Feb 2008 | parenteral nutrition-associated cholestasis, pulmonary immaturity | B. Braun Melsungen AG | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lipofundin MCT/LCT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00497289 ↗ |
| Route | Intravenous | “daily i.v. infusion for up to 5 days” NCT00497289 ↗ |